🇺🇸 FDA
Patent

US 10583111

Method for preventing or treating diseases associated with the inhibition of EGFR

granted A61KA61K31/34A61K45/06

Quick answer

US patent 10583111 (Method for preventing or treating diseases associated with the inhibition of EGFR) held by ONQUALITY PHARMACEUTICALS CHINA LTD. expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONQUALITY PHARMACEUTICALS CHINA LTD.
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/34, A61K45/06, A61K9/0014, A61K9/06